The University of Auckland National Institute for Health Innovation have started recruitment for two new Auckland-based smoking cessation trials, led by Professor Chris Bullen and Associate Professor Natalie Walker.
The University of Auckland are also currently running an e-cigarette trial, for which they seek to enrol participants across NZ.
New: STATUS trial
The STATUS trial is for people with alcohol/drug addictions and/or mental health problems who want to quit smoking. The trial aims to find out if combining Champix with an e-cigarette or with Zyban will be more effective compared to only Champix, in people who don’t respond to the first 2 weeks of Champix.
Study website: http://status.nihi.auckland.ac.nz
Facebook: https://www.facebook.com/STATUS-Trial-1295241623908543/
Protocol summary
New: SPACE trial
The SPACE trial is for people with COPD who want to quit smoking. The trial aims to find out if extending a regular Champix treatment (plus behavioural support) will prevent COPD patients who have quit successfully after taking Champix for 12 weeks (plus behavioural support) from relapsing back to smoking compared to a placebo (plus behavioural support).
Study website: http://space.nihi.auckland.ac.nz
Facebook: https://www.facebook.com/SPACE-Trial-296722050784046/
Protocol summary
ASCEND-II trial
The ASCEND-II trial aims to determine the effectiveness and safety of combining nicotine patches with an e-cigarette (with or without nicotine), plus behavioural support.
Study website: http://ascend2@nihi.auckland.ac.nz
Facebook: https://www.facebook.com/ASCEND2trial/
Protocol summary
